Patents by Inventor Carole Henry

Carole Henry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEASONAL RNA INFLUENZA VIRUS VACCINES
    Publication number: 20230000970
    Abstract: The disclosure provides RNA vaccines for seasonal influenza virus as well as methods of using the vaccines.
    Type: Application
    Filed: January 10, 2022
    Publication date: January 5, 2023
    Applicant: ModernaTX, Inc.
    Inventors: Raffael Nachbagauer, Carole Henry, Patricia Jorquera
  • Truncated CD20 protein, deltaCD20
    Patent number: 9388468
    Abstract: Diagnostic kit comprising an oligonucleotide probe for the mRNA encoding a polypeptide having an amino acid sequence substantially identical to that of SEQ ID NO: 2.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: July 12, 2016
    Assignee: ETABLISSEMENT FRANCAIS DU SANG
    Inventors: Christophe Ferrand, Marina Deschamps, Carole Henry, Pierre Tiberghien, Christophe Borg, Pierre-Simon Rohrlich
  • TRUNCATED CD20 PROTEIN, DELTACD20
    Publication number: 20140316125
    Abstract: Isolated nucleic acid sequence encoding the CD20 gene comprising SEQ ID NO: 5, recombinant vector comprising a nucleic acid sequence placed under the control of one or a plurality of elements required for the expression thereof in a host cell, and method for improving the efficacy of a treatment comprising using a nucleic acid sequence comprising SEQ ID NO: 5.
    Type: Application
    Filed: June 13, 2014
    Publication date: October 23, 2014
    Inventors: Christophe Ferrand, Marina Deschamps, Carole Henry, Pierre Tiberghien, Christophe Borg, Pierre-Simon Rohrlich
  • Truncated CD20 protein, deltaCD20
    Patent number: 8759503
    Abstract: Isolated nucleic acid sequence encoding the CD20 gene comprising SEQ ID NO: 5, recombinant vector comprising a nucleic acid sequence placed under the control of one or a plurality of elements required for the expression thereof in a host cell, and method for improving the efficacy of a treatment comprising using a nucleic acid sequence comprising SEQ ID NO: 5.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: June 24, 2014
    Assignee: Etablissement Francais du Sang
    Inventors: Christophe Ferrand, Marina Deschamps, Carole Henry, Pierre Tiberghien, Christophe Borg, Pierre-Simon Rohrlich
  • TRUNCATED CD20 PROTEIN, DELTACD20
    Publication number: 20120129167
    Abstract: The present invention relates in particular to a protein from an alternative splicing of the gene encoding CD20, the nucleic acid sequences encoding the protein according to the invention, a mutated form of the CD20 gene as well as drugs, diagnostic tools, diagnostic methods and treatment methods using the protein and the nucleic acid sequences according to the invention.
    Type: Application
    Filed: November 17, 2009
    Publication date: May 24, 2012
    Applicant: ETABLISSEMENT FRANCAIS DU SANG (EFS)
    Inventors: Christophe Ferrand, Marina Deschamps, Carole Henry, Pierre Tiberghien, Christophe Borg, Pierre-Simon Rohrlich